Biocorrx Inc (BICX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,038 | -2,229 | -852 | -5,212 | -3,985 |
| Depreciation Amortization | 608 | 403 | 201 | 1,197 | 951 |
| Accounts receivable | -216 | -51 | -112 | 1 | 1 |
| Other Working Capital | 465 | 523 | -339 | 1,523 | 1,159 |
| Other Operating Activity | 730 | 538 | 412 | 1,395 | 1,024 |
| Operating Cash Flow | $-1,451 | $-816 | $-690 | $-1,096 | $-849 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 942 | 848 | 633 | 1,132 | 793 |
| Debt Repayment | -7 | -7 | -7 | -11 | -9 |
| Common Stock Issued | 716 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | -1 | 0 | -1 | 0 |
| Financing Cash Flow | $1,650 | $840 | $626 | $1,119 | $784 |
| Beginning Cash Position | 88 | 88 | 88 | 65 | 65 |
| End Cash Position | 288 | 112 | 24 | 88 | 0 |
| Net Cash Flow | $200 | $24 | $-64 | $23 | $-65 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,451 | -816 | -690 | -1,096 | -849 |
| Free Cash Flow | -1,451 | -816 | -690 | -1,096 | -849 |